195 related articles for article (PubMed ID: 32957477)
21. The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor.
Chopra M; Yao Y; Blake TJ; Hampson DR; Johnson EC
J Pharmacol Exp Ther; 2009 Jul; 330(1):212-9. PubMed ID: 19389924
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of N-acetyl-aspartyl-glutamate on synaptic and extrasynaptic NMDA receptors are subunit- and pH-dependent in the CA1 region of the mouse hippocampus.
Khacho P; Wang B; Ahlskog N; Hristova E; Bergeron R
Neurobiol Dis; 2015 Oct; 82():580-592. PubMed ID: 26303888
[TBL] [Abstract][Full Text] [Related]
23. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons.
Bergeron R; Coyle JT; Tsai G; Greene RW
Neuropsychopharmacology; 2005 Jan; 30(1):7-16. PubMed ID: 15354184
[TBL] [Abstract][Full Text] [Related]
24. The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats.
Pöschel B; Wroblewska B; Heinemann U; Manahan-Vaughan D
Cereb Cortex; 2005 Sep; 15(9):1414-23. PubMed ID: 15635057
[TBL] [Abstract][Full Text] [Related]
25. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
[TBL] [Abstract][Full Text] [Related]
26. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
27. Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats.
Bubeníková-Valesová V; Balcar VJ; Tejkalová H; Langmeier M; St'astný F
Neurochem Int; 2006; 48(6-7):515-22. PubMed ID: 16540202
[TBL] [Abstract][Full Text] [Related]
28. A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition.
Neale JH; Olszewski R
Neurobiol Learn Mem; 2019 Feb; 158():9-13. PubMed ID: 30630041
[TBL] [Abstract][Full Text] [Related]
29. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats.
Zhong C; Zhao X; Sarva J; Kozikowski A; Neale JH; Lyeth BG
J Neurotrauma; 2005 Feb; 22(2):266-76. PubMed ID: 15716632
[TBL] [Abstract][Full Text] [Related]
30. Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat.
Malomouzh AI; Nikolsky EE; Lieberman EM; Sherman JA; Lubischer JL; Grossfeld RM; Urazaev AKh
J Neurochem; 2005 Jul; 94(1):257-67. PubMed ID: 15953368
[TBL] [Abstract][Full Text] [Related]
31. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia.
Baslow MH; Dyakin VV; Nowak KL; Hungund BL; Guilfoyle DN
J Mol Neurosci; 2005; 26(1):1-15. PubMed ID: 15968081
[TBL] [Abstract][Full Text] [Related]
32. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.
Wroblewska B; Wroblewski JT; Pshenichkin S; Surin A; Sullivan SE; Neale JH
J Neurochem; 1997 Jul; 69(1):174-81. PubMed ID: 9202308
[TBL] [Abstract][Full Text] [Related]
33. Similar neuroprotective effects of ischemic and hypoxic preconditioning on hypoxia-ischemia in the neonatal rat: a proton MRS study.
Seo H; Lim KH; Choi JH; Jeong SM
Int J Dev Neurosci; 2013 Nov; 31(7):616-23. PubMed ID: 23958850
[TBL] [Abstract][Full Text] [Related]
34. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
Romei C; Raiteri M; Raiteri L
Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408
[TBL] [Abstract][Full Text] [Related]
35. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture.
Westbrook GL; Mayer ML; Namboodiri MA; Neale JH
J Neurosci; 1986 Nov; 6(11):3385-92. PubMed ID: 3021930
[TBL] [Abstract][Full Text] [Related]
36. Self-Regulation of Cerebral Metabolism and Its Neuroprotective Effect After Hypoxic-Ischemic Injury: Evidence From
Li K; Zheng Y; Wang X
Front Neuroanat; 2021; 15():672412. PubMed ID: 34220456
[No Abstract] [Full Text] [Related]
37. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
Neale JH; Olszewski RT; Gehl LM; Wroblewska B; Bzdega T
Trends Pharmacol Sci; 2005 Sep; 26(9):477-84. PubMed ID: 16055199
[TBL] [Abstract][Full Text] [Related]
38. N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats.
Lu XM; Tang Z; Liu W; Lin Q; Slusher BS
Eur J Pharmacol; 2000 Nov; 408(3):233-9. PubMed ID: 11090639
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.
Nijboer CH; Bonestroo HJ; Zijlstra J; Kavelaars A; Heijnen CJ
Neurobiol Dis; 2013 Jun; 54():432-44. PubMed ID: 23376684
[TBL] [Abstract][Full Text] [Related]
40. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
